162 related articles for article (PubMed ID: 1594550)
1. Involvement of endogenous cholecystokinin in pancreatic regeneration after cerulein-induced acute pancreatitis.
Jurkowska G; Grondin G; Morisset J
Pancreas; 1992; 7(3):295-304. PubMed ID: 1594550
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin antagonist prevents hyperamylasemia and improves pancreatic exocrine function in cerulein-induced acute pancreatitis.
Murayama KM; Drew JB; Nahrwold DL; Joehl RJ
Pancreas; 1990 Jul; 5(4):439-44. PubMed ID: 1696383
[TBL] [Abstract][Full Text] [Related]
3. Role of endogenous cholecystokinin in the regeneration of pancreatic tissue after acute hemorrhagic pancreatitis in rats.
Song W; Yamaguchi H; Nakano I; Kimura T; Nawata H
Fukuoka Igaku Zasshi; 1996 Jan; 87(1):14-22. PubMed ID: 8820983
[TBL] [Abstract][Full Text] [Related]
4. The role of cholecystokinin in the pathogenesis of acute pancreatitis in the isolated pancreas preparation.
Nordback IH; Clemens JA; Cameron JL
Surgery; 1991 Mar; 109(3 Pt 1):301-6. PubMed ID: 1705726
[TBL] [Abstract][Full Text] [Related]
5. CCK administration after CCK receptor blockade accelerates recovery from cerulein-induced acute pancreatitis in rats.
Nakano S; Kihara Y; Otsuki M
Pancreas; 1998 Mar; 16(2):169-75. PubMed ID: 9510141
[TBL] [Abstract][Full Text] [Related]
6. Soybean trypsin inhibitor and cerulein accelerate recovery of cerulein-induced pancreatitis in rats.
Jurkowska G; Grondin G; Massé S; Morisset J
Gastroenterology; 1992 Feb; 102(2):550-62. PubMed ID: 1370663
[TBL] [Abstract][Full Text] [Related]
7. Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals.
Zucker KA; Adrian TE; Bilchik AJ; Modlin IM
Am J Physiol; 1989 Oct; 257(4 Pt 1):G511-6. PubMed ID: 2478030
[TBL] [Abstract][Full Text] [Related]
8. Effect of the cholecystokinin receptor antagonist loxiglumide on pancreatic exocrine function in rats after acute pancreatitis.
Nakano S; Tachibana I; Otsuki M
Pancreas; 1995 Apr; 10(3):287-94. PubMed ID: 7542770
[TBL] [Abstract][Full Text] [Related]
9. Effect of chronic administration of hydrocortisone on the induction and evolution of acute pancreatitis induced by cerulein.
Pescador R; Manso MA; Rebollo AJ; de Dios I
Pancreas; 1995 Aug; 11(2):165-72. PubMed ID: 7479674
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of pancreatic tyrosine kinase and phospholipase D activities in the course of cerulein-induced acute pancreatitis and during regeneration.
Rydzewska G; Rivard N; Morisset J
Pancreas; 1995 May; 10(4):382-8. PubMed ID: 7792295
[TBL] [Abstract][Full Text] [Related]
11. Alteration of cholecystokinin receptor binding after caerulein-induced pancreatitis in rats.
Yazu T; Kimura T; Sumii T; Nawata H
Digestion; 1991; 50(3-4):142-8. PubMed ID: 1725866
[TBL] [Abstract][Full Text] [Related]
12. Effects of early decompression and cholecystokinin inhibition in rats with acute pancreatitis induced by bile-pancreatic-duct obstruction.
de Dios I; Urunuela A; Manso M
J Lab Clin Med; 2003 Apr; 141(4):265-71. PubMed ID: 12677172
[TBL] [Abstract][Full Text] [Related]
13. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin antagonist L364,718 induces alterations in acinar cells that prevent improvement of acute pancreatitis induced by obstruction.
De Dios I; Uruñuela A; Orfao A; Manso MA
Dig Dis Sci; 2002 Aug; 47(8):1800-9. PubMed ID: 12184533
[TBL] [Abstract][Full Text] [Related]
15. Fasting prevents acute pancreatitis induced by cerulein in rats.
Otsuki M; Tani S; Okabayashi Y; Fujii M; Nakamura T; Fujisawa T; Koide M; Itoh H
Dig Dis Sci; 1990 Jul; 35(7):840-8. PubMed ID: 2364838
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
Louie DS; Liang JP; Owyang C
Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
[TBL] [Abstract][Full Text] [Related]
17. Asperlicin, a nonpeptidal cholecystokinin receptor antagonist, attenuates sodium taurocholate-induced acute pancreatitis in rats.
Wisner JR; Renner IG
Pancreas; 1988; 3(2):174-9. PubMed ID: 2453874
[TBL] [Abstract][Full Text] [Related]
18. The effect of endogenous cholecystokinin released by bombesin and trypsin inhibitor on the regeneration of the pancreas.
Parekh D; Ishizuka J; Townsend CM; Rajaraman S; Thompson JC
Ann Surg; 1993 Dec; 218(6):735-41. PubMed ID: 8257223
[TBL] [Abstract][Full Text] [Related]
19. Effect of long-term CCK blockade on the pancreatic acinar cell renewal in rats with acute pancreatitis.
de la Mano AM; Sevillano S; Manso MA; de Dios I
Peptides; 2003 Apr; 24(4):535-41. PubMed ID: 12860197
[TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin blockade triggers earlier and enhanced intra-acinar oxygen free radical generation in acute pancreatitis induced by pancreatic duct obstruction in rats.
Uruñuela A; Manso MA; de la Mano AM; de Dios I
Clin Sci (Lond); 2003 Aug; 105(2):203-12. PubMed ID: 12713440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
